Benzothiazoles - scaffold of interest for CNS targeted drugs
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F15%3A10292871" target="_blank" >RIV/00216208:11160/15:10292871 - isvavai.cz</a>
Alternative codes found
RIV/60162694:G44__/15:43875336 RIV/62690094:18470/15:50003418 RIV/00179906:_____/15:10292871
Result on the web
<a href="http://benthamscience.com/journals/current-medicinal-chemistry/volume/22/issue/6/page/730/" target="_blank" >http://benthamscience.com/journals/current-medicinal-chemistry/volume/22/issue/6/page/730/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/0929867322666141212120631" target="_blank" >10.2174/0929867322666141212120631</a>
Alternative languages
Result language
angličtina
Original language name
Benzothiazoles - scaffold of interest for CNS targeted drugs
Original language description
Benzothiazole compounds represent heterocyclic systems comprising a benzene ring fused with a thiazole ring containing nitrogen and sulphur in its structure. Besides the presence of a benzothiazole core in naturally occurring molecules, synthesized compounds containing a benzothiazole moiety in their structure proved to be a significant class of potential therapeutics, as they exhibit biological effects such as antitumor, antibacterial, antitubercular, antiviral, anthelmintic, antidiabetic and many others. Apart from the aforementioned peripheral or microbial active sites, benzothiazole analogues are also biologically active compounds in the central nervous system, where some approved drugs containing a benzothiazole moiety have already been identifiedand are used in the treatment of various neurological disorders. New benzothiazole molecules are currently under development and are being evaluated for several uses including diagnostics and as therapeutic drug candidates for the treatm
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Current Medicinal Chemistry
ISSN
0929-8673
e-ISSN
—
Volume of the periodical
22
Issue of the periodical within the volume
6
Country of publishing house
AE - UNITED ARAB EMIRATES
Number of pages
18
Pages from-to
730-747
UT code for WoS article
000349388600006
EID of the result in the Scopus database
2-s2.0-84931265913